CVS Health Corporation $CVS Shares Purchased by Poinciana Advisors Group LLC

Poinciana Advisors Group LLC increased its holdings in CVS Health Corporation (NYSE:CVS) by 51.1% during the 2nd quarter, Holdings Channel.com reports. The institutional investor owned 5,036 shares of the pharmacy operator’s stock after purchasing an additional 1,704 shares during the quarter. Poinciana Advisors Group LLC’s holdings in CVS Health were worth $347,000 at the end of the most recent reporting period.

Other large investors have also made changes to their positions in the company. Bell Investment Advisors Inc raised its holdings in CVS Health by 119.8% in the 1st quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock valued at $31,000 after acquiring an additional 248 shares during the last quarter. Roxbury Financial LLC lifted its position in CVS Health by 78.3% during the 2nd quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock worth $32,000 after acquiring an additional 202 shares in the last quarter. ORG Partners LLC increased its stake in CVS Health by 418.9% during the 2nd quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator’s stock worth $32,000 after buying an additional 377 shares during the period. Saudi Central Bank purchased a new position in CVS Health in the first quarter valued at about $34,000. Finally, Livelsberger Financial Advisory acquired a new stake in CVS Health in the second quarter valued at $35,000. Institutional investors and hedge funds own 80.66% of the company’s stock.

Insider Activity

In other news, Director Anne A. Finucane sold 7,500 shares of the firm’s stock in a transaction dated Wednesday, August 20th. The stock was sold at an average price of $71.02, for a total transaction of $532,650.00. Following the sale, the director owned 22,156 shares of the company’s stock, valued at $1,573,519.12. This trade represents a 25.29% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.22% of the stock is owned by company insiders.

CVS Health Trading Down 0.3%

Shares of CVS stock opened at $75.52 on Tuesday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.62 and a current ratio of 0.80. The firm has a fifty day moving average of $69.41 and a 200-day moving average of $67.07. The stock has a market cap of $95.78 billion, a price-to-earnings ratio of 21.10, a P/E/G ratio of 0.84 and a beta of 0.62. CVS Health Corporation has a 52-week low of $43.56 and a 52-week high of $77.34.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.46 by $0.35. The firm had revenue of $98.92 billion during the quarter, compared to the consensus estimate of $94.87 billion. CVS Health had a net margin of 1.17% and a return on equity of 10.51%. The firm’s quarterly revenue was up 8.4% on a year-over-year basis. During the same period last year, the firm posted $1.83 EPS. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. On average, equities research analysts forecast that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, November 3rd. Stockholders of record on Thursday, October 23rd will be given a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 3.5%. The ex-dividend date is Thursday, October 23rd. CVS Health’s payout ratio is presently 74.30%.

Analysts Set New Price Targets

A number of brokerages have weighed in on CVS. Cantor Fitzgerald reissued an “overweight” rating and set a $78.00 target price on shares of CVS Health in a report on Tuesday, August 26th. Cowen reissued a “buy” rating on shares of CVS Health in a report on Monday, August 4th. Baird R W upgraded shares of CVS Health from a “hold” rating to a “strong-buy” rating in a report on Thursday, August 14th. Sanford C. Bernstein increased their price target on CVS Health from $72.00 to $77.00 and gave the company a “market perform” rating in a research report on Friday, September 5th. Finally, Jefferies Financial Group increased their target price on CVS Health from $74.00 to $80.00 and gave the company a “buy” rating in a report on Monday, June 30th. Two analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $78.25.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.